Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-05-17

Clinical Trial Update: Inflammation-related Alterations in Neurocircuitry: Reversal With Levodopa [Phase 4]

View source ↗

Summary

Phase 4 trial investigating whether Levodopa reverses inflammation-related neurocircuitry alterations associated with depression; study completed with posted re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • levodopa (levodopa)

Snippet

Sponsor: Emory University | Conditions: Depression | Phase 4 | Status: COMPLETED | Results posted: 2022-05-17